>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Tampilkan postingan dengan label Rp850. Tampilkan semua postingan
Tampilkan postingan dengan label Rp850. Tampilkan semua postingan

Selasa, 04 Mei 2010

Mandiri Sekuritas Mitra Adiperkasa: 1Q10 Within our and consensus estimate (MAPI, Rp850, BUY, TP:Rp880)

Mitra has less seasonality. In 2009, revenue from 1Q09/FY09 was 22.6%, while 1Q09 operating profit was 14.4% of FY09 operating profit. Hence we considered 1Q10 operational performances are within our expectation with a slight upward bias. At Rp690/share, MAPI is trading at 6.0x and 5.3x PER10F, and PER11F, respectively.

Mandiri Sekuritas Ramayana : 1Q10 Within our and consensus estimate (RALS, Rp850, SELL, TP:Rp800)

Evaluating RALS performance is through looking at seasonality in revenue. Ramayana 1Q revenue at the lowest was 15.5% and the highest was 18.6% of total revenue from the year. In 1Q10, RALS sales were 14.3% of FY10F of ours and 14.5% of FY10 according to Bloomberg consensus. However, this was due to a change in reporting format. Using the old format (where sales incorporate number from inhouse and consignment), total revenue was 17.7% of our FY10F. Therefore we conclude the performance as within our estimate. Details have yet to be obtained. We have a Sell recommendation as RALS share price performance has already inputted an expectation of strong performances this year.
At Rp850/share, RALS is trading at 15.2x and 13.0x PER10F, and PER11F, respectively.

Kamis, 01 April 2010

Mandiri Sekuritas SMRA: FY Result slightly below our consensus (SMRA, Rp850, Buy, TP: 730)

􀂄 SMRA’s booked net revenue FY09 Rp1.98 bn (-5,4% yoy), slightly below our estimates and consensus. The slip mainly due to global economic recession over the year that giving impact to company’s marketing sales target, especially its Serpong property (-10,9% yoy). However, the gross margin increased to 64% FY09, compared to 61% FY08, led to the bottom line grew (+77.8%). For 2010, SMRA targeted growth in net profit by 15%, as this will mainly result from the booked revenue from the newly opened site in Bekasi. SMRA is currently trading at a discount of 14.1% to its NAV. We are currently reviewing our forecast and assumption.

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News